Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long‐term followup of a prospective clinical trialD. M. C. Brinkman, Jaak M. Vossen, I. M. de Kleer et al.|Arthritis & Rheumatism|2007Cited by 144
The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritisH M Albers, R. ten Cate, Willem Verduijn et al.|Annals of the Rheumatic Diseases|2008Cited by 55
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-studyP Müller, R. ten Cate, D. M. C. Brinkman et al.|Pediatric Rheumatology|2017Cited by 43
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Janneke Anink, Lisette W. A. van Suijlekom‐Smit, M.H. Otten et al.|Lara D. Veeken|2013Cited by 40
Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritisH M Albers, R. ten Cate, D. M. C. Brinkman et al.|Arthritis Care & Research|2010Cited by 36